Boston Scientific Corp. (BSX) Tops Q3 EPS by 8c; Guides Q4 EPS Below Views
Boston Scientific Corp. (NYSE: BSX) reported Q3 EPS of $0.17, $0.08 better than the analyst estimate of $0.09. Revenue for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
